- Home
- ATYR vs KRNY Comparison
ATYR vs KRNY Comparison
Compare ATYR & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- KRNY
- Stock Information
- Founded
- ATYR 2005
- KRNY 1884
- Country
- ATYR United States
- KRNY United States
- Employees
- ATYR N/A
- KRNY N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- KRNY Savings Institutions
- Sector
- ATYR Health Care
- KRNY Finance
- Exchange
- ATYR Nasdaq
- KRNY Nasdaq
- Market Cap
- ATYR 451.3M
- KRNY 389.4M
- IPO Year
- ATYR 2015
- KRNY 2005
- Fundamental
- Price
- ATYR $5.35
- KRNY $6.48
- Analyst Decision
- ATYR Strong Buy
- KRNY Buy
- Analyst Count
- ATYR 5
- KRNY 2
- Target Price
- ATYR $23.25
- KRNY $7.75
- AVG Volume (30 Days)
- ATYR 5.0M
- KRNY 353.2K
- Earning Date
- ATYR 08-07-2025
- KRNY 07-24-2025
- Dividend Yield
- ATYR N/A
- KRNY 6.80%
- EPS Growth
- ATYR N/A
- KRNY N/A
- EPS
- ATYR N/A
- KRNY 0.42
- Revenue
- ATYR N/A
- KRNY $151,629,000.00
- Revenue This Year
- ATYR $478.72
- KRNY $13.01
- Revenue Next Year
- ATYR $1,899.26
- KRNY N/A
- P/E Ratio
- ATYR N/A
- KRNY $15.51
- Revenue Growth
- ATYR N/A
- KRNY 12.84
- 52 Week Low
- ATYR $1.67
- KRNY $5.45
- 52 Week High
- ATYR $7.29
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- ATYR 52.99
- KRNY 62.75
- Support Level
- ATYR $4.58
- KRNY $6.00
- Resistance Level
- ATYR $5.03
- KRNY $6.13
- Average True Range (ATR)
- ATYR 0.34
- KRNY 0.15
- MACD
- ATYR -0.01
- KRNY 0.05
- Stochastic Oscillator
- ATYR 66.09
- KRNY 98.57
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.